Signaling plasticity in pre-clinical models of resistance to KRAS-G12C inhibitors

被引：0
|
作者：
Ambrogio, Chiara [1 ]
机构：
[1] Dept Mol Biotechnol & Hlth Sci, Turin, Italy
来源：
CANCER SCIENCE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S21-7
引用
收藏
页码：1738 / 1738
页数：1
相关论文
共 50 条
  • [1] Adaptive resistance to KRAS-G12C inhibitors through AXL activation in KRAS-G12C mutant tumor cells
    Morimoto, Kenji
    Yamada, Tadaaki
    Hirai, Soichi
    Katayama, Yuki
    Yano, Seiji
    Horinaka, Mano
    Sakai, Toshiyuki
    Tokuda, Shinsaku
    Takayama, Koichi
    CANCER SCIENCE, 2024, 115 : 111 - 111
  • [2] The KRAS-G12C inhibitor: activity and resistance
    Jiao Liu
    Rui Kang
    Daolin Tang
    Cancer Gene Therapy, 2022, 29 : 875 - 878
  • [3] The KRAS-G12C inhibitor: activity and resistance
    Liu, Jiao
    Kang, Rui
    Tang, Daolin
    CANCER GENE THERAPY, 2022, 29 (07) : 875 - 878
  • [4] Identification of novel peptide inhibitors for the KRas-G12C variant to prevent oncogenic signaling
    Ajmal, Amar
    Ali, Yasir
    Khan, Ajmal
    Wadood, Abdul
    Rehman, Ashfaq Ur
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023, 41 (18): : 8866 - 8875
  • [5] KRAS-G12C in the crosshairs
    Sarah Seton-Rogers
    Nature Reviews Cancer, 2020, 20 : 3 - 3
  • [6] Establishment of KRAS-G12C inhibitor induced resistant tumor models enable the development of new generation KRAS-G12C inhibitors and combinatorial strategies.
    Liu, Gaoxiang
    Shi, Wenting
    Gu, Qingyang
    Ji, Qunsheng
    CANCER RESEARCH, 2021, 81 (13)
  • [7] Correction: The KRAS-G12C inhibitor: activity and resistance
    Jiao Liu
    Rui Kang
    Daolin Tang
    Cancer Gene Therapy, 2023, 30 : 1715 - 1715
  • [8] KRAS-G12C in the crosshairs
    Seton-Rogers, Sarah
    NATURE REVIEWS CANCER, 2020, 20 (01) : 3 - 3
  • [9] Repotrectinib increases effectiveness of KRAS-G12C inhibitors in KRAS-G12C mutant cancer models via simultaneous SRC/FAK/JAK2 inhibition
    Cui, J. Jean
    Zhai, Dayong
    Deng, Wei
    Rodon, Laura
    Lee, Nathan
    Murray, Brion
    CANCER RESEARCH, 2020, 80 (16)
  • [10] Combination Therapies to Maximize the Impact of KRAS-G12C Inhibitors
    Molina-Arcas, M.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S97 - S97
12345